LLGL2 Increases Ca2+ Influx and Exerts Oncogenic Activities via PI3K/AKT Signaling Pathway in Hepatocellular Carcinoma

被引:10
|
作者
Leng, Shusheng [1 ,2 ,3 ]
Xie, Fei [4 ]
Liu, Junyi [5 ]
Shen, Junyi [1 ,2 ]
Quan, Guangqian [1 ,2 ]
Wen, Tianfu [1 ,2 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Liver Surg, Chengdu, Peoples R China
[2] Sichuan Univ, West China Hosp, Liver Transplantat Ctr, Chengdu, Peoples R China
[3] Chengdu Univ, Clin Med Coll, Affiliated Hosp, Gen Surg Dept, Chengdu, Peoples R China
[4] First Peoples Hosp Neijiang City, Dept Hepatobiliary Pancreat & Splen Surg, Neijiang, Peoples R China
[5] Chengdu Univ, Clin Med Coll, Affiliated Hosp, Cent Lab, Chengdu, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2021年 / 11卷
关键词
LLGL2; Hepatocellular Carcinoma; PI3K; AKT signaling; Calcium influx; Progression; HUMAN HOMOLOG; DROSOPHILA; LGL; HUGL-1; POLARITY; EXPRESSION; MORPHOGENESIS; DIVISION; CLONING; GROWTH;
D O I
10.3389/fonc.2021.683629
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Lethal giant larvae (Lgl), scaffolding proteins, regulate the epithelial cell apicobasal polarity in Drosophila. They play important roles in asymmetric cell division, cell migration, and progenitor cells self-renewal as tumor suppressors. One of Lgl mammalian homologues proteins, LLGL2 overexpression has been reported in ER+ breast cancer and promotes tumor proliferation through regulating leucine uptake. Nonetheless, the role of LLGL2 in hepatocellular carcinoma (HCC) is still unknown. Methods TCGA dataset mining, qRT-PCR, Western blot along with immunohistochemistry assays were employed to explore LLGL2 expression in human HCC samples and cell lines. Moreover, the clinical value of LLGL2 was investigated in 156 HCC patients. Furthermore, the role as well as the molecular mechanism of LLGL2 in the progression of HCC was explored through a series of in vitro and in vivo experiments. Results LLGL2 was up-regulated in HCC tissues, which was related with certain clinicopathological features including tumor number, vascular invasion as well as advanced stage. High expression of LLGL2 predicted poor prognosis after hepatectomy. LLGL2 promoted HCC cells proliferation, migration and invasion through PI3K/ATK signaling by promoting calcium ion influx. Conclusion Our study identified that LLGL2 is a tumor promoter in HCC for the first time, which could potentially be utilized as a new biomarker and a therapeutic target for HCC.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway
    Zhang, Zhenyu
    Zhu, Jinfeng
    Huang, Yansong
    Li, Weibing
    Cheng, Hongqiu
    DIAGNOSTIC PATHOLOGY, 2018, 13
  • [32] IMMT promotes hepatocellular carcinoma formation via PI3K/AKT/mTOR pathway
    Wang, Jiabei
    Zhang, Yunguang
    Sun, Linmao
    Liu, Yao
    ONCOLOGIE, 2023, 25 (06) : 691 - 703
  • [33] Artemisiae Iwayomogii Herba Inhibits Growth, Motility, and the PI3K/AKT/mTOR Signaling Pathway in Hepatocellular Carcinoma Cells
    Kim, Juyoung
    Jung, Kyung Hee
    Choi, Jin Gyu
    Oh, Myung Sook
    Hong, Soon-Sun
    PLANTA MEDICA, 2020, 86 (10) : 717 - 727
  • [34] The role of PI3K/AKT signaling pathway in gallbladder carcinoma
    Wu, Zeyu
    Yu, Xiao
    Zhang, Shuijun
    He, Yuting
    Guo, Wenzhi
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2022, 14 (07): : 4426 - 4442
  • [35] NCAPG Promotes The Proliferation Of Hepatocellular Carcinoma Through PI3K/AKT Signaling
    Gong, Chengwu
    Ai, Jiyuan
    Fan, Yun
    Gao, Jun
    Liu, Weiwei
    Feng, Qian
    Liao, Wenjun
    Wu, Linquan
    ONCOTARGETS AND THERAPY, 2019, 12 : 8537 - 8552
  • [36] Hypoxia-induced TUFT1 promotes the growth and metastasis of hepatocellular carcinoma by activating the Ca2+/PI3K/AKT pathway
    Dou, Changwei
    Zhou, Zhenyu
    Xu, Qiuran
    Liu, Zhikui
    Zeng, Yuqun
    Wang, Yufeng
    Li, Qing
    Wang, Liang
    Yang, Wei
    Liu, Qingguang
    Tu, Kangsheng
    ONCOGENE, 2019, 38 (08) : 1239 - 1255
  • [37] Evaluating Oncogenic Drivers and Therapeutic Potential of the PI3K/AKT/mTOR Pathway in Hepatocellular Carcinoma: An Overview of Clinical Trials
    Khorasani, Ayda Baghery Saghchy
    Delshad, Mahda
    Sanaei, Mohammad-Javad
    Pourbagheri-Sigaroodi, Atieh
    Pirsalehi, Ali
    Bashash, Davood
    BIOCELL, 2025,
  • [38] Dehydrocostus Lactone Reduced Malignancy of HepG2 Human Hepatocellular Carcinoma Cells via Down-Regulation of the PI3K/AKT Signaling Pathway
    Gu, W.
    Zhao, H.
    Yuan, H.
    Zhao, S.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2023, 174 (03) : 360 - 364
  • [39] ASIC1a mediates the drug resistance of human hepatocellular carcinoma via the Ca2+/PI3-kinase/AKT signaling pathway
    Zhang, Yihao
    Zhang, Ting
    Wu, Chao
    Xia, Quan
    Xu, Dujuan
    LABORATORY INVESTIGATION, 2017, 97 (01) : 53 - 69
  • [40] APLN promotes hepatocellular carcinoma through activating PI3K/Akt pathway and is a druggable target
    Chen, Huarong
    Wong, Chi-Chun
    Liu, Dabin
    Go, Minnie Y. Y.
    Wu, Bin
    Peng, Sui
    Kuang, Ming
    Wong, Nathalie
    Yu, Jun
    THERANOSTICS, 2019, 9 (18): : 5246 - 5260